3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
6
Neoplasms
5
Multiple Myeloma
5
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leiomyoma
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Hematologic Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Vomiting
1
Venous Thromboembolism
1
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Thalassemia
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Substitutes
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Post-operative Seroma Formation
1
Polycythemia Vera
1
Pituitary Neoplasms
1
Interventions
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Thoracic Neoplasms
×
30 days
×
Clear all
NCT07279935
2026-06-01
REVIVE
AstraZeneca
Phase 4
Recruiting
100 enrolled